5-Azacytidine: Mechanism of action and biological effects in mammalian cells

[1]  B. Hoogstraten,et al.  5‐azacytidine in acute leukemia , 1978, Cancer.

[2]  A. Čihák,et al.  Stimulatory Effect of 5-Azacytidine on 7S Antibody Production in Rats , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  A. Čihák.  Transformation of 5-aza-2'-deoxycytidine-3H and its incorporation in different systems of rapidly proliferating cells. , 1978, European journal of cancer.

[4]  W. Reutter,et al.  Lower gastric secretion and higher incorporation of orotic acid into liver RNA in rats treated with 5-azacytidine and cycloheximide. , 1978, Neoplasma.

[5]  J. Veselý,et al.  Effects of 5-aza-2'-deoxycytidine on DNA synthesis in mouse lymphatic tissues. , 1978, Neoplasma (Bratislava).

[6]  F. Máliš,et al.  Inhibitory effect of various cytostatics and cycloheximide on acute experimental pancreatitis in rats. , 1977, Gut.

[7]  J. Veselý,et al.  Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. , 1977, Cancer research.

[8]  R. Momparler,et al.  In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine. , 1977, Cancer research.

[9]  T. E. Webb,et al.  Uridine kinase activities and pyrimidine nucleoside phosphorylation in fluoropyrimidine-sensitive and -resistant cell lines of the Novikoff hepatoma. , 1977, The Biochemical journal.

[10]  W. Sadee,et al.  Synthesis of 5-azacytidine-6-13C and -6-14C. , 1977, Journal of medicinal chemistry.

[11]  T. E. Webb,et al.  Uridine kinase activities in normal and neoplastic lymphoid cells. , 1977, Cancer research.

[12]  R. Momparler,et al.  Kinetic studies with 5-azacytidine-5'-triphosphate and DNA-dependent RNA polymerase. , 1977, Biochemical pharmacology.

[13]  C. Presant,et al.  Biological characterization of a prolonged antileukemic effect of 5-azacytidine. , 1977, Cancer Research.

[14]  P. Voytek,et al.  Comparison of the cytostatic action, phosphorylation and deamination of 5-azacytidine and 5,6-dihydro-5-azacytidine in l1210 and hela cells. Abstr. , 1977 .

[15]  H. Eyre,et al.  Phase II study of 5-azacytidine in solid tumors. , 1977, Cancer treatment reports.

[16]  B. Chabner,et al.  Characteristics of the enzyme uridine-cytidine kinase isolated from a cultured human cell line. , 1977, Biochemical pharmacology.

[17]  J. Beisler,et al.  Dihydro-5-azacytidine hydrochloride, a biologically active and chemically stable analog of 5-azacytidine. , 1976, Cancer treatment reports.

[18]  D. Miller,et al.  5-Azacytidine (NSC 102816): a new drug for the treatment of myeloblastic leukemia. , 1976, Blood.

[19]  T. Lee,et al.  Inhibition of protein synthesis in 5-azacytidine-treated HeLa cells. , 1976, Biochemical pharmacology.

[20]  D. V. Von Hoff,et al.  5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia. , 1976, Annals of internal medicine.

[21]  T G O'Brien,et al.  The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. , 1976, Cancer research.

[22]  J. Burchenal,et al.  Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside. , 1976, Cancer Research.

[23]  J. Pirkle,et al.  The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusion. , 1976, Cancer research.

[24]  G. Neil,et al.  Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine. , 1976, Cancer Research.

[25]  R. Momparler,et al.  Enzymatic synthesis of 5-azacytidine 5'-triphosphate from 5-azacytidine. , 1976, Analytical Biochemistry.

[26]  K. Randerath,et al.  Drug effects on nucleic acid modification. I. A specific effect of 5-azacytidine on mammalian transfer RNA methylation in vivo. , 1976, Biochemical and biophysical research communications.

[27]  S. Siegel,et al.  Effect of tRNA from 5-azacytidine-treated hamster fibrosarcoma cells on protein synthesis in vitro in a cell-free system. , 1976, Biochemical pharmacology.

[28]  J. Veselý,et al.  Enhanced mortality in offsprings of male mice treated with 5-azacytidine prior to mating. Morphological changes in testes. , 1976, Neoplasma.

[29]  T. Lee,et al.  Inhibition of uridine-cytidine kinase by 5-azacytidine 5'-triphosphate. , 1976, Medical and Pediatric Oncology.

[30]  P. Riches,et al.  Enhanced incorporation of thymidine into DNA in the liver of intact and partially hepatectomized rats pretreated with 5-azacytidine. , 1976, Cancer research.

[31]  Lomen Pl,et al.  Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 days. , 1975 .

[32]  C. N. Coleman,et al.  Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes. , 1975, Blood.

[33]  A. Čihák.  Character of the stimulatory response of uridine kinase in rat livers to cycloheximide treatment. , 1975, European journal of biochemistry.

[34]  R. Momparler,et al.  In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination. , 1975, Cancer Research.

[35]  R. Momparler,et al.  Cellular Phosphorylation of 1-β-d-Arabinofuranosylcytosine and 5-Azacytidine with Intact Fibrosarcoma and Leukemic Cells , 1975 .

[36]  W. Ph,et al.  Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia. , 1975 .

[37]  C. K. Chu,et al.  Nucleosides XCII. A facile synthesis of 5-(β-d-ribofuranosyl)- isocytosine (ψ-isocytidine) , 1975 .

[38]  C. Presant,et al.  Kinetics of both leukemic and normal cell population reduction following 5-azacytidine. , 1975, Cancer research.

[39]  T. E. Webb,et al.  Early temporal changes in the uridine kinase isozyme profile of the Novikoff hepatoma in response to 5-azacytidine treatment. , 1975, Biochemical pharmacology.

[40]  R. Notari,et al.  Kinetics and mechanisms of degradation of the antileukemic agent 5-azacytidine in aqueous solutions. , 1975, Journal of pharmaceutical sciences.

[41]  R. Boutwell,et al.  Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. , 1975, Cancer research.

[42]  S. Kuentzel,et al.  Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. , 1975, Cancer chemotherapy reports.

[43]  H. Pitot,et al.  Effects of 5-azacytidine on nucleolar RNA and the preribosomal particles in Novikoff hepatoma cells. , 1975, Biochemistry.

[44]  V. Altanerová.  Transformation of BHK 21/13 cells by chemical carcinogens and mutagens. , 1975, Neoplasma.

[45]  J. Veselý.  Activity of uridine kinase in different lines of AKR leukemic mice and its relation to chemotherapy with 5‐azacytidine , 1974, International journal of cancer.

[46]  H. Pitot,et al.  Alteration of ribosomal precursor RNA in Novikoff hepatoma cells by 5-azacytidine. Studies on methylation of 45S and 32S RNA. , 1974, Archives of biochemistry and biophysics.

[47]  Farrar We,et al.  Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae. , 1974 .

[48]  W. Vogler,et al.  Phase I study of twice weekly 5-azacytidine (NSC-102816). , 1974, Cancer chemotherapy reports.

[49]  H. Pitot,et al.  Characterization of polyribosomes and maturation of ribosomal RNA in hepatoma cells treated with 5-azacytidine. , 1974, Cancer research.

[50]  R. Momparler,et al.  Kinetic studies on phosphorylation of 5-azacytidine with the purified uridine-cytidine kinase from calf thymus. , 1974, Cancer research.

[51]  H. Morris,et al.  5-azacytidine-modified patterns of uridine kinase activities in normal and neoplastic tissues. , 1974, Cancer research.

[52]  D. Mcnamara,et al.  Glucagon-mediated changes in the concentration of rat hepatic tyrosine transaminase: an immunochemical analysis. , 1974, Archives of biochemistry and biophysics.

[53]  L. Korbová,et al.  Impaired gastric secretion in rats treated with 5-azacytidine. , 1974, Archives internationales de pharmacodynamie et de therapie.

[54]  K. Harrap,et al.  Enhancement of rat liver uridine kinase activity by various metabolic inhibitors. , 1974, Biochemical pharmacology.

[55]  P. Engstrom,et al.  Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816). , 1974, Cancer chemotherapy reports.

[56]  A. Čihák.  Modulation of orotate phosphoribosyltransferase and orotidine 5'-phosphate decarboxylase activities in regenerating rat liver by 5-azacytidine , 1974 .

[57]  J. Veselý,et al.  Characterization of depressed uridine kinase in rat thymus following 5-azacytidine administration , 1974 .

[58]  A. Čihák.  Biological effects of 5-azacytidine in eukaryotes. , 1974, Oncology.

[59]  H. Pitot,et al.  Inhibition of ribosomal ribonucleic acid maturation by 5-azacytidine and 8-azaguanine in Novikoff hepatoma cells. , 1974, Archives of biochemistry and biophysics.

[60]  H. Rabes,et al.  Modulatory effect of cytostatics and chemical carcinogens on liver regeneration (a review). , 1974, Neoplasma.

[61]  F. Schabel,et al.  Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. , 1974, Cancer research.

[62]  G. Stoner,et al.  Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. , 1973, Cancer research.

[63]  E. Freireich,et al.  Treatment of acute leukemia with 5-azacytidine (NSC-102816). , 1973, Cancer chemotherapy reports.

[64]  B. Chabner,et al.  Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase. , 1973, Biochemical pharmacology.

[65]  S. Penman,et al.  The mechanism of inhibition of protein synthesis by 5-azacytidine in HeLa cells. , 1973, Biochimica et biophysica acta.

[66]  J. Finklestein,et al.  5-Azacytidine: a new active agent for the treatment of acute leukemia. , 1973, Blood.

[67]  J. Veselý,et al.  Uridine kinase in embryonic rat liver. Modulation of enzyme activity by 5-azacytidine. , 1973, The Biochemical journal.

[68]  D. Mcnamara,et al.  A common component involved in the induction of hepatic tyrosine transaminase by hydrocortisone and glucagon. , 1973, Biochimica et biophysica acta.

[69]  H. Pitot,et al.  Studies on the mechanism of the stimulation of tyrosine aminotransferase activity in vivo by pyrimidine analogs: the role of enzyme synthesis and degradation. , 1973, Archives of biochemistry and biophysics.

[70]  H. Pitot,et al.  Labeling of Cytoplasmic Liver RNA by [6‐14C]Orotic and 5‐Fluoro[2‐14C]orotic Acids , 1973 .

[71]  J. Veselý,et al.  Enhanced uridine kinase in rat liver following 5-azacytidine administration. In vivo characterization and properties of partially purified enzyme. , 1973, The Journal of biological chemistry.

[72]  S. Penman,et al.  Destructive processing of the 45-S ribosomal precursor in the presence of 5-azacytidine. , 1973, Biochimica et biophysica acta.

[73]  H. Pitot,et al.  Degradation of rat liver polyribosomes following the administration of 5-azacytidine stability of attached non-ribosomal ribonucleic acids , 1973 .

[74]  F. Šorm,et al.  Metabolic alterations of liver regeneration. XI. Modulation of the uptake of orotic acid into ribonucleic acids in regenerating rat liver , 1973 .

[75]  Custer Rp,et al.  Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study). , 1973 .

[76]  D. Russell,et al.  Depression of polyamine synthesis in L1210 leukemic mice during treatment with a potent antileukemic agent, 5-azacytidine. , 1973, Cancer research.

[77]  J. Veselý,et al.  Effect of 5-azacytidine and 6-azauridine on the synthesis of DNA in embryonic mouse brain mitotic activity and migration of ventricular cells. , 1973, Neoplasma.

[78]  R. Adams,et al.  Effect of 5-azacytidine on phytohemagglutinin-stimulated horse lymphocytes and cultured mouse L929 cells. , 1973, Cancer research.

[79]  J. Veselý,et al.  Prolongation of the lag period preceding the enhancement of thymidine and thymidylate kinase activity in regenerating rat liver by 5-azacytidine. , 1972, Biochemical pharmacology.

[80]  R. Tobey.  Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse. , 1972, Cancer research.

[81]  V. Altanerova.  Virus production induced by various chemical carcinogens in a virogenic hamster cell line transformed by Rous sarcoma virus. , 1972, Journal of the National Cancer Institute.

[82]  W. Benedict,et al.  Chromatid Breakage: Differential Effect of Inhibitors of DNA Synthesis during G2 Phase , 1972, Science.

[83]  H. H. Lloyd,et al.  Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816). , 1972, Cancer chemotherapy reports.

[84]  H. Pitot,et al.  Effects of 5-azacytidine on dietary and hormone induction of serine dehydratase and tyrosine aminotransferase in rat liver. , 1972, Biochemical pharmacology.

[85]  A. Čihák,et al.  Dual effect of 5-azacytidine on the synthesis of liver ribonucleic acids. Lack of the relationship between metabolic transformation of orotic acid in vitro and its incorporation in vivo. , 1972, Biochemical pharmacology.

[86]  D. Martin,et al.  Repression and derepression of purine biosynthesis in mammalian hepatoma cells in culture. , 1972, The Journal of biological chemistry.

[87]  F. Šorm,et al.  Metabolic alterations of liver regeneration. VIII. Enhanced synthesis of DNA in the liver of 5‐azacytidine‐treated rats subjected to partial hepatectomy , 1972, International journal of cancer.

[88]  J. Stambaugh,et al.  Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man. , 1972, Cancer chemotherapy reports.

[89]  M. Mastrangelo,et al.  Phase I study of 5-azacytidine (NSC-102816) . , 1972, Cancer chemotherapy reports.

[90]  T. E. Webb,et al.  Modified induction of ornithine decarboxylase by factors which affect liver regeneration. , 1972, Biochimica et biophysica acta.

[91]  R. G. Krueger,et al.  The effect of actinomycin D and 5-azacytidine on macromolecular synthesis in murine myeloma tumor cells. , 1972, Journal of immunology.

[92]  J. Veselý,et al.  Enhanced uridine kinase and RNA synthesis in regenerating rat liver after 5-azacytidine administration. , 1972, Archives of biochemistry and biophysics.

[93]  T. J. Fraser,et al.  Cell cycle phase specificity of antitumor agents. , 1972, Cancer research.

[94]  V. Altanerová,et al.  Characterization of chicken sarcoma viruses induced with chemical carcinogens and mutagens in transformed hamster cells. , 1972, Neoplasma.

[95]  F. Šorm,et al.  The determination of 5‐azapyrimidines and their derivatives in bacterial RNA , 1971, FEBS letters.

[96]  H. Pitot,et al.  Inhibition of ribosomal ribonucleic acid maturation in rat liver by 5-fluoroorotic acid resulting in the selective labeling of cytoplasmic messenger ribonucleic acid. , 1971, The Journal of biological chemistry.

[97]  M. Shimada,et al.  Cerebral cortex of the mouse after prenatal chemical insult. , 1971, The American journal of anatomy.

[98]  F. Šorm,et al.  Enhanced stability of uridine kinase from mouse leukemic cells resistant to 5-azacytidine. Thermal inactivation and effect of p-chloromercuribenzoate. , 1971, European journal of biochemistry.

[99]  G. Krystal,et al.  Multiple forms of uridine kinase in normal and neoplastic rat liver. , 1971, The Biochemical journal.

[100]  F. Šorm,et al.  Biochemical mechanisms of drug resistance — XII. Uridine kinases from mouse leukemic cells sensitive and resistant to 5‐azacytidine , 1971, International journal of cancer.

[101]  I. Levitan,et al.  Tyrosine transaminase induction: differential effect of 5-azacytidine on liver and hepatoma 5123D. , 1971, Biochimica et biophysica acta.

[102]  R. Baserga,et al.  Inhibition of isoproterenol-stimulated deoxyribonucleic acid synthesis by 5-azacytidine. , 1971, Laboratory investigation; a journal of technical methods and pathology.

[103]  J. Veselý,et al.  5-azacytidine in childhood leukemia. , 1971, Neoplasma.

[104]  C C Cheng,et al.  Common receptor-complement feature among some antileukemic compounds. , 1970, Journal of pharmaceutical sciences.

[105]  L H Li,et al.  Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia. , 1970, Cancer research.

[106]  L. Li,et al.  Phase specificity of 5-azacytidine against mammalian cells in tissue culture. , 1970, Cancer research.

[107]  F. Šorm,et al.  Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. , 1970, Cancer research.

[108]  V. Glišin,et al.  The effect of 5-azacytidine on development, nucleic acid and protein metabolism in sea urchin embryos. , 1970, Biochemical and biophysical research communications.

[109]  A. Goldin,et al.  Reduction of Antileukemic and Immunosuppressive Activities of 5-Azacytidine in Mice by Concurrent Treatment with Uridine 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[110]  I. Levitan,et al.  Hydrocortisone-mediated changes in the concentration of tyrosine transaminase in rat liver: an immunochemical study. , 1970, Journal of molecular biology.

[111]  F. Šorm,et al.  The mode of action of 5-aza-2'-deoxycytidine in Escherichia coli. , 1970, European Journal of Biochemistry.

[112]  A. Goldin,et al.  Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice. , 1970, Cancer research.

[113]  R. Pittillo,et al.  5-azacytidine: microbiological assay in mouse blood. , 1969, Applied microbiology.

[114]  I. Levitan,et al.  Effects of 5-azacytidine on polyribosomes and on the control of tyrosine transaminase activity in rat liver. , 1969, Biochimica et biophysica acta.

[115]  F. Šorm,et al.  Substrate-induced tryptophan pyrrolase in rat liver after 5-azacytidine administration , 1969 .

[116]  F. Šorm,et al.  Biochemical mechanisms of drug resistance. IX. Metabolic alterations in leukemic mouse cells following 5-aza-2'-deoxycytidine , 1969 .

[117]  J. Veselý,et al.  Altered liver regeneration in partially hepatectomized rats following 5-azacytidine treatment , 1969 .

[118]  F. Šorm,et al.  Radioprotective Effect of 5-Azacytidine in AKR Mice , 1969, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete.

[119]  F. Šorm,et al.  Characteristics of mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. , 1968, Cancer research.

[120]  G. W. Camiener.  Studies of the enzymatic deamination of ara-cytidine. V. inhibition in vitro and in vivo by tetrahydrouridine and other reduced pyrimidine nucleosides. , 1968, Biochemical pharmacology.

[121]  F. Šorm,et al.  Thymidine kinase and polyribosome distribution in regerating rat liver following 5-azacytidine. , 1968, Biochimica et biophysica acta.

[122]  F. Šorm,et al.  Biochemical mechanism of drug resistance. VII. Inhibition of orotic acid metabolism by 5-azacytidine in leukemic mice sensitive and resistant to 5-azacytidine. , 1968, Biochemical pharmacology.

[123]  F. Šorm,et al.  Enhanced triphosphatase activity of mouse leukemic cells resistant to 5-azacytidine , 1968 .

[124]  V. Paces,et al.  The effect of azapyrimidine nucleosides and deoxynucleosides on the metabolism of thymidine and thymine in cultures of Escherichia coli , 1968 .

[125]  F. Šorm,et al.  Effect of 5-aza-2'-deoxycytidine against leukemic and hemopoietic tissues in AKR mice. , 1968, Neoplasma.

[126]  F. Šorm,et al.  Biochemical mechanisms of drug resistance IV. Development of resistance to 5‐azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice , 1967, International journal of cancer.

[127]  F. Šorm,et al.  Complete inhibition by 5-azacytidine of hormonal induction of tryptophan pyrrolase , 1967 .

[128]  F. Šorm,et al.  Differences in the inhibition of hormone and substrate induction of rat liver tryptophan pyrrolase by 5-azacytidine , 1967 .

[129]  A. D. Welch,et al.  Immunosuppression by pyrimidine nucleoside analogs. , 1966, Biochemical pharmacology.

[130]  J. Pitha,et al.  THE SPECIFICITY OF HYDROGEN BOND FORMATION BETWEEN DERIVATIVES OF NUCLEIC ACID BASES AND SOME ANALOGUES , 1966 .

[131]  F. Šorm,et al.  Biochemical changes associated with the development of resistance to 5‐azacytidine in AKR leukemic mice , 1966, International journal of cancer.

[132]  F. Šorm,et al.  Metabolic effects of 5-azacytidine in isolated nuclei of calf-thymus cells , 1966 .

[133]  F. Šorm,et al.  Effect of 5-azacytidine on the acceptor activity of sRNA , 1966 .

[134]  F. Šorm,et al.  Anabolic transformations of 5-azacytidine in mouse brain , 1966 .

[135]  F. Šorm,et al.  Incorporation of 5-azacytidine-4-[ 14 C] and of cytidine-[ 3 H] into ribonucleic acids of mouse Ehrlich ascites tumour cells , 1966 .

[136]  A. Dietz,et al.  Microbiological production of 5-azacytidine. I. Production and biological activity. , 1966, Antimicrobial agents and chemotherapy.

[137]  F. Šorm,et al.  Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine. , 1965, Biochimica et biophysica acta.

[138]  F. Šorm,et al.  Biochemical effects and metabolic transformations of 5-azacytidine in Escherichia coli , 1965 .

[139]  F. Šorm,et al.  Anabolic transformation of a novel antimetabolite, 5-azacytidine, and evidence for its incorporation into ribonucleic acid , 1965 .

[140]  F. Šorm,et al.  Nucleic acids components and their analogues. LXVI. Hydrolysis of 5-azacytidine and its connection with biological activity , 1965 .

[141]  F. Šorm,et al.  On the metabolism of 5-azacytidine and 5-aza-2'-deoxycytidine in mice , 1965 .

[142]  F. Šorm,et al.  THE CYTOLOGIC AND THE METABOLIC EFFECTS OF A NEW ANTILEUKEMIC ANALOGUE 5-AZACYTIDINE IN NORMAL MICE FOLLOWED AUTORADIOGRAPHICALLY WITH TRITIUM. , 1965, Neoplasma.

[143]  F. Šorm,et al.  Synthesis of a 2-deoxy-D-ribofuranosyl-5-azacytosine , 1964 .

[144]  F. Šorm,et al.  Nucleic acids components and their analogues. LI. Synthesis of 1-glycosyl derivatives of 5-azauracil and 5-azacytosine , 1964 .

[145]  F. Šorm,et al.  Formation of 5-azauridine, ribosyl N-formylbiuret, ribosyl biuret, and their 5'-phosphates in Escherichia coli culture from 5-azauracil , 1964 .

[146]  F. Šorm,et al.  THE ACTIVITY OF A NEW ANTIMETABOLITE, 5-AZACYTIDINE, AGAINST LYMPHOID LEUKAEMIA IN AK MICE. , 1964, Neoplasma.

[147]  F. Šorm,et al.  Determination of uridine kinase activity in some human tumours and normal tissues, using 4,5-14-C-6-azauridine as substrate. , 1963, Neoplasma.

[148]  I. Grigorov,et al.  [On the cytochemistry of polyphosphates in Aspergillus oryzae]. , 1962, Acta histochemica.